Masato Odawara

Effect of an intensified multifactorial intervention on cardiovascular outcomes and mortality in type 2 diabetes (J-DOIT3): an open-label, randomised controlled trial

Kohjiro Ueki, Takayoshi Sasako, Yukiko Okazaki et al. · The Lancet Diabetes & Endocrinology · 2017 · 300 citations

Non-pharmacological Intervention, Diabetes Management, Cardiovascular Disease +9

Association Between Plasma Triglycerides and High-Density Lipoprotein Cholesterol and Microvascular Kidney Disease and Retinopathy in Type 2 Diabetes Mellitus

Frank M. Sacks, Michel P. Hermans, Paola Fioretto et al. · Circulation · 2013 · 251 citations · Full text

Human Diabetes Associated with a Mutation in the Tyrosine Kinase Domain of the Insulin Receptor

Masato Odawara, Takashi Kadowaki, Ritsuko Yamamoto et al. · Science · 1989 · 191 citations

Genetics, Molecular Biology, Insulin Receptor +21

Paraoxonase Polymorphism (Gln192-Arg) Is Associated with Coronary Heart Disease in Japanese Noninsulin-Dependent Diabetes Mellitus

Masato Odawara, Yoichi Tachi, Kamejiro Yamashita · The Journal of Clinical Endocrinology & Metabolism · 1997 · 147 citations · Full text

Genetic Epidemiology, Human Polymorphism, Pona Gene +18

Once‐weekly glucagon‐like peptide‐1 receptor agonist dulaglutide is non‐inferior to once‐daily liraglutide and superior to placebo in <scp>J</scp> apanese patients with type 2 diabetes: a 26‐week randomized phase <scp>III</scp> study

Jun‐ichiro Miyagawa, Masato Odawara, Toshinari Takamura et al. · Diabetes Obesity and Metabolism · 2015 · 93 citations · Full text